Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center.
Argirò A, Zampieri M, Dei LL, Ferrantini C, Marchi A, Tomberli A, Baldini K, Cappelli F, Favilli S, Passantino S, Zocchi C, Tassetti L, Gabriele M, Maurizi N, Marchionni N, Coppini R, Olivotto I.
Argirò A, et al.
Int J Cardiol. 2023 Jan 1;370:271-278. doi: 10.1016/j.ijcard.2022.10.014. Epub 2022 Oct 10.
Int J Cardiol. 2023.
PMID: 36228766